More from Renaissance Capital
Referenced Stocks

Pfizer's animal health unit Zoetis prices IPO at $26, above the range

By Renaissance Capital,  January 31, 2013, 04:59:37 PM EDT

Zoetis, a spin-off of Pfizer's global animal health medicines and vaccines business, raised $2.2 billion by offering 86.1 million shares at $26, above the range of $22 to $25. Zoetis plans to list on the NYSE under the symbol ZTS. J.P. Morgan, BofA Merrill Lynch and Morgan Stanley acted as lead managers on the deal.




The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of The NASDAQ OMX Group, Inc.


This article appears in: News Headlines, IPOs

Referenced Stocks: ZTS



Latest News Video

San Antonio Flash Flood Kills 1, Prompts Evacuations
San Antonio Flash Flood Kills 1, Pr...


Sign-in
Existing NASDAQ.com member? Log in here.

By signing into to the site using any of the third-party services above, you agree to NASDAQ.com's Terms of Use.

From Our Trusted News Source





Most Active by Volume:

Company Last Sale Change Net / %
BAC $ 13.24 0.03  0.23%
FB $ 24.32 0.74  2.95%
SIRI $ 3.58 0.04  0.99%
GE $ 23.53 0.13  0.55%
PFE $ 29.04 0.07  0.24%
MSFT $ 34.27 0.12  0.35%
INTC $ 23.93 0.12  0.50%
P $ 16.43 0.73  4.25%